BioCentury
ARTICLE | Clinical News

Buprenorphine hemiadipate: Phase I data

May 16, 2016 7:00 AM UTC

Indivior said the open-label, U.K. Phase I RB-EU-14-0001 trial in healthy volunteers showed that oral RBP-6300 did not achieve “the anticipated PK profile in humans to justify proceeding further with ...